Kinome and Transcriptome profiling reveal broad and distinct activities of Erlotinib, Sunitinib, and Sorafenib in the mouse heart and suggest cardiotoxicity from combined signal transducer and activator of transcription and epidermal growth factor receptor inhibition

T. J. Stuhlmiller; J. S. Zawistowski; X. Chen; N. Sciaky; S. P. Angus; S. T. Hicks; T. L. Parry; W. Huang; J. Y. Beak; M. S. Willis; G. L. Johnson; B. C. Jensen

doi:10.1161/jaha.117.006635

Kinome and Transcriptome profiling reveal broad and distinct activities of Erlotinib, Sunitinib, and Sorafenib in the mouse heart and suggest cardiotoxicity from combined signal transducer and activator of transcription and epidermal growth factor receptor inhibition

T. J. Stuhlmiller, J. S. Zawistowski, X. Chen, N. Sciaky, S. P. Angus, S. T. Hicks, T. L. Parry, W. Huang, J. Y. Beak, M. S. Willis, G. L. Johnson, B. C. Jensen

Campbell University

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	Journal of the American Heart Association
Volume	6
DOIs	https://doi.org/10.1161/jaha.117.006635
State	Published - Oct 19 2017

Disciplines

Pharmacy and Pharmaceutical Sciences

Access to Document

10.1161/jaha.117.006635License: Unspecified

Kinome and Transcriptome profiling reveal broad and distinct actiFinal published version, 3.08 MBLicense: Unspecified

Cite this

Stuhlmiller, T. J., Zawistowski, J. S., Chen, X., Sciaky, N., Angus, S. P., Hicks, S. T., Parry, T. L., Huang, W., Beak, J. Y., Willis, M. S., Johnson, G. L., & Jensen, B. C. (2017). Kinome and Transcriptome profiling reveal broad and distinct activities of Erlotinib, Sunitinib, and Sorafenib in the mouse heart and suggest cardiotoxicity from combined signal transducer and activator of transcription and epidermal growth factor receptor inhibition. Journal of the American Heart Association, 6. https://doi.org/10.1161/jaha.117.006635

Kinome and Transcriptome profiling reveal broad and distinct activities of Erlotinib, Sunitinib, and Sorafenib in the mouse heart and suggest cardiotoxicity from combined signal transducer and activator of transcription and epidermal growth factor receptor inhibition. / Stuhlmiller, T. J.; Zawistowski, J. S.; Chen, X. et al.
In: Journal of the American Heart Association, Vol. 6, 19.10.2017.

Research output: Contribution to journal › Article › peer-review

Stuhlmiller, TJ, Zawistowski, JS, Chen, X, Sciaky, N, Angus, SP, Hicks, ST, Parry, TL, Huang, W, Beak, JY, Willis, MS, Johnson, GL & Jensen, BC 2017, 'Kinome and Transcriptome profiling reveal broad and distinct activities of Erlotinib, Sunitinib, and Sorafenib in the mouse heart and suggest cardiotoxicity from combined signal transducer and activator of transcription and epidermal growth factor receptor inhibition', Journal of the American Heart Association, vol. 6. https://doi.org/10.1161/jaha.117.006635

Stuhlmiller TJ, Zawistowski JS, Chen X, Sciaky N, Angus SP, Hicks ST et al. Kinome and Transcriptome profiling reveal broad and distinct activities of Erlotinib, Sunitinib, and Sorafenib in the mouse heart and suggest cardiotoxicity from combined signal transducer and activator of transcription and epidermal growth factor receptor inhibition. Journal of the American Heart Association. 2017 Oct 19;6. doi: 10.1161/jaha.117.006635

Stuhlmiller, T. J. ; Zawistowski, J. S. ; Chen, X. et al. / Kinome and Transcriptome profiling reveal broad and distinct activities of Erlotinib, Sunitinib, and Sorafenib in the mouse heart and suggest cardiotoxicity from combined signal transducer and activator of transcription and epidermal growth factor receptor inhibition. In: Journal of the American Heart Association. 2017 ; Vol. 6.

@article{dc680dd0fb7f48039dae77753e84d4b9,

title = "Kinome and Transcriptome profiling reveal broad and distinct activities of Erlotinib, Sunitinib, and Sorafenib in the mouse heart and suggest cardiotoxicity from combined signal transducer and activator of transcription and epidermal growth factor receptor inhibition",

author = "Stuhlmiller, {T. J.} and Zawistowski, {J. S.} and X. Chen and N. Sciaky and Angus, {S. P.} and Hicks, {S. T.} and Parry, {T. L.} and W. Huang and Beak, {J. Y.} and Willis, {M. S.} and Johnson, {G. L.} and Jensen, {B. C.}",

year = "2017",

month = oct,

day = "19",

doi = "10.1161/jaha.117.006635",

language = "American English",

volume = "6",

journal = "Journal of the American Heart Association",

}

TY - JOUR

T1 - Kinome and Transcriptome profiling reveal broad and distinct activities of Erlotinib, Sunitinib, and Sorafenib in the mouse heart and suggest cardiotoxicity from combined signal transducer and activator of transcription and epidermal growth factor receptor inhibition

AU - Stuhlmiller, T. J.

AU - Zawistowski, J. S.

AU - Chen, X.

AU - Sciaky, N.

AU - Angus, S. P.

AU - Hicks, S. T.

AU - Parry, T. L.

AU - Huang, W.

AU - Beak, J. Y.

AU - Willis, M. S.

AU - Johnson, G. L.

AU - Jensen, B. C.

PY - 2017/10/19

Y1 - 2017/10/19

UR - https://cufind.campbell.edu/pharmacy/2331

U2 - 10.1161/jaha.117.006635

DO - 10.1161/jaha.117.006635

M3 - Article

VL - 6

JO - Journal of the American Heart Association

JF - Journal of the American Heart Association

ER -

Kinome and Transcriptome profiling reveal broad and distinct activities of Erlotinib, Sunitinib, and Sorafenib in the mouse heart and suggest cardiotoxicity from combined signal transducer and activator of transcription and epidermal growth factor receptor inhibition

Disciplines

Access to Document

Other files and links

Cite this